Transgenomic News

Transgenomic, Inc. announced today the launch of its SURVEYOR Scan K-RAS kit, the first in a family of mutation detection kits the company plans to offer featuring its proprietary SURVEYOR Nuclease and WAVE A HS DHPLC platform.

OMAHA, Neb., Oct. 29 /PRNewswire-FirstCall/ -- Transgenomic Inc. announces the following Webcast: Conference Call When:__ Thursday, November 5, 2009 @ 5:00 p.m. Eastern Where:__ http://www.transgenomic.com/events.asp?id=6 How:__ Live over the Internet -- Simply log on to the web at the address above.

Transgenomic, Inc. . The company announced today that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from the Dana-Farber Cancer Institute , Boston, MA.

Our Stocks to Watch tomorrow include Blue Diamond Ventures Inc. , Power3 Medical Products Inc.

Transgenomic, Inc. and Power3 Medical Products, Inc. announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.

Transgenomic Inc., an Omaha biotechnology company, Wednesday reported a second-quarter loss of $730,000, a penny a share, on a 12 percent decline in sales.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.